Desktop Site |
13 Nov 25 | 16:00 | Close
Equity SME Eq Drv Currency Commodity Corporates
Get Quote
Notices |
BSE SENSEX 84,478.67 +12.16 +0.01 %
Corporate Announcement
  • Security Code532296
    CompanyGlenmark Pharmaceuticals Ltd
    Exchange Received Time03/11/2025 17:34:47
    Exchange Disseminated Time03/11/2025 17:34:48
    Time Taken00:00:01
     
     
     Board Meeting Intimation for Considering And Approving The Unaudited Financial Results Of The Company For The Second Quarter And Half Year Ended September 30, 2025 | 11/03/25 17:34 
     Glenmark Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve the Unaudited Financial Results of the Company for the second quarter and half year ended September 30, 2025 
    AttachmentDownload PDF
     
    << Back  
     
Recently Viewed
Copyright@ 2015. All Rights Reserved. BSE Ltd.
(24) 14 Nov 25|06:17 (IST)